EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

NAD metabolism modulates inflammation and mitochondria function in diabetic kidney disease

Komuraiah Myakala, Xiaoxin X Wang, Nataliia V Shults, Ewa Krawczyk, Bryce A Jones, Xiaoping Yang, Avi Z Rosenberg, Brandon Ginley, Pinaki Sarder, Leonid Brodsky, Yura Jang, Chan Hyun Na und 13 weitere

Journal of Biological Chemistry · 2023

DOI: 10.1016/j.jbc.2023.104975 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Biological Chemistry, 2023. Verfasst von Komuraiah Myakala und 24 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biochemistry and Molecular & Cellular Biology, Georgetown University, Washington, District of Columbia, USA. Hauptthemen laut MEDLINE: Diabetic Nephropathies, Diabetes Mellitus, Experimental, Diabetes Mellitus, Type 2. Die Arbeit wurde bisher 83-mal zitiert (Crossref) und nennt 63 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: NIDDK NIH HHS, NCATS NIH HHS, National Institutes of Health.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Diabetes mellitus is the leading cause of cardiovascular and renal disease in the United -States. Despite the beneficial interventions available for patients with diabetes, there remains a need for additional therapeutic targets and therapies in diabetic kidney disease (DKD). Inflammation and oxidative stress are increasingly recognized as important causes of renal diseases. Inflammation is closely associated with mitochondrial damage. The molecular connection between inflammation and mitochondrial metabolism remains to be elucidated. Recently, nicotinamide adenine nucleotide (NAD+) metabolism has been found to regulate immune function and inflammation. In the present studies, we tested the hypothesis that enhancing NAD metabolism could prevent inflammation in and progression of DKD. We found that treatment of db/db mice with type 2 diabetes with nicotinamide riboside (NR) prevented several manifestations of kidney dysfunction (i.e., albuminuria, increased urinary kidney injury marker-1 (KIM1) excretion, and pathologic changes). These effects were associated with decreased inflammation, at least in part via inhibiting the activation of the cyclic GMP-AMP synthase-stimulator of interferon genes (cGAS-STING) signaling pathway. An antagonist of the serum stimulator of interferon genes (STING) and whole-body STING deletion in diabetic mice showed similar renoprotection. Further analysis found that NR increased SIRT3 activity and improved mitochondrial function, which led to decreased mitochondrial DNA damage, a trigger for mitochondrial DNA leakage which activates the cGAS-STING pathway. Overall, these data show that NR supplementation boosted NAD metabolism to augment mitochondrial function, reducing inflammation and thereby preventing the progression of diabetic kidney disease.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Diabetic NephropathiesDiabetes Mellitus, ExperimentalDiabetes Mellitus, Type 2MiceAnimalsNADMitochondriaDNA, MitochondrialNucleotidyltransferasesInflammationInterferons

Stichwörter der Autor:innen

NADcGAS-STINGdiabetic kidney diseaseinflammation, diabetesmitochondriamitochondrial DNA damagesirtuin 3

Substanzen

NADDNA, MitochondrialNucleotidyltransferasesInterferons

Autor:innen und Institutionen

  • Department of Biochemistry and Molecular & Cellular Biology, Georgetown University, Washington, District of Columbia, USA.
  • Department of Biochemistry and Molecular & Cellular Biology, Georgetown University, Washington, District of Columbia, USA. Electronic address: Xiaoxin.Wang@georgetown.edu.
  • Department of Pharmacology and Physiology, Georgetown University, Washington, District of Columbia, USA.
  • Department of Pathology, Johns Hopkins University, Baltimore, Maryland, USA.
  • Departments of Pathology and Anatomical Sciences, SUNY, Buffalo, New York, USA.
  • Department of Medicine-Quantitative Health, Department of Electrical and Computer Engineering, University of Florida, Gainesville, Florida, USA.

Förderung

  • NIDDK NIH HHS
  • NCATS NIH HHS
  • National Institutes of Health
  • American Heart Association
  • National Center for Advancing Translational Sciences
  • Georgetown University

Zitieren

APA

Myakala, K., Wang, X. X., Shults, N. V., Krawczyk, E., Jones, B. A., Yang, X., Rosenberg, A. Z., Ginley, B., Sarder, P., Brodsky, L., Jang, Y., Na, C. H., Qi, Y., Zhang, X., Guha, U., Wu, C., Bansal, S., Ma, J., Cheema, A., …, & Levi, M. (2023). NAD metabolism modulates inflammation and mitochondria function in diabetic kidney disease. Journal of Biological Chemistry. https://doi.org/10.1016/j.jbc.2023.104975

Vancouver

Myakala K, Wang XX, Shults NV, Krawczyk E, Jones BA, Yang X, et al. NAD metabolism modulates inflammation and mitochondria function in diabetic kidney disease. Journal of Biological Chemistry. 2023. doi:10.1016/j.jbc.2023.104975

BibTeX
@article{Myakala2023,
  author = {Myakala, Komuraiah and Wang, Xiaoxin X and Shults, Nataliia V and Krawczyk, Ewa and Jones, Bryce A and Yang, Xiaoping and Rosenberg, Avi Z and Ginley, Brandon and Sarder, Pinaki and Brodsky, Leonid and Jang, Yura and Na, Chan Hyun and Qi, Yue and Zhang, Xu and Guha, Udayan and Wu, Ci and Bansal, Shivani and Ma, Junfeng and Cheema, Amrita and Albanese, Chris and Hirschey, Matthew D and Yoshida, Teruhiko and Kopp, Jeffrey B and Panov, Julia and Levi, Moshe},
  title = {NAD metabolism modulates inflammation and mitochondria function in diabetic kidney disease},
  journal = {Journal of Biological Chemistry},
  year = {2023},
  doi = {10.1016/j.jbc.2023.104975}
}
Kostenlos starten →